Effect of perioperative glutamine-enriched nutritional support on patients with colorectal cancer: A systematic
Yong Huang1,2, Xiu-Zhi Yang1,2, Song-Han Qin1,2
1Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China.
Background:
Colorectal cancer (CRC) is a common malignant tumor of the digestive system that poses a serious threat to human health. During the perioperative period, patients with CRC are prone to nutritional risks and malnutrition. Compared with traditional nutritional support, immunostimulatory nutrients, including glutamine (Gln), have attracted increasing attention. Although many previous studies have reported that perioperative Gln supplementation can improve short-term clinical outcomes in patients with CRC, some studies have not demonstrated a benefit. Resolution of Gln supplementation value thus requires further exploration.
Aim:
To clarify the influence of perioperative Gln-enhanced nutritional support on postoperative outcomes including nutritional status, immune function, inflammation levels, morbidity due to complications, and length of hospital stay (LOS).
Methods:
A comprehensive literature search was conducted (inception to June 2025). PubMed, EMBASE, Web of Science, Cochrane Library, China Biomedical Database, CNKI, VIP, and the Wanfang Electronic Database were searched. This meta-analysis ultimately included 27 studies with a total of 1643 patients; 827 patients received perioperative Gln treatment and 816 received conventional nutritional therapy. A random-effects model was used to pool relative risks (RR) and mean differences (MD) with 95% confidence intervals (CI).
Results:
Pooled analysis showed that Gln intervention reduced morbidity associated with postoperative infectious complications (RR = 0.36; 95%CI: 0.24-0.54) and non-infectious complications (RR = 0.32; 95%CI: 0.19-0.55) and shortened the LOS by 2.31 days (MD = -2.31; 95%CI: -3.21 to -1.41) in CRC patients. Gln supplementation also increased serum albumin, prealbumin, peripheral blood lymphocyte count, and nitrogen balance levels and improved humoral and cellular immune function. We also found that postoperative tumor necrosis factor-α and C-reactive protein levels were lower in Gln-supplemented patients. By contrast, Gln supplementation did not improve CD8+ and CD4+/CD8+ levels.
Conclusion:
Gln supplementation effectively improved short-term clinical outcomes in patients with CRC.
More Related Videos
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...